ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenCellerys AG
Cellerys AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Cellerys AG is the development of therapies for the treatment of autoimmune diseases, particularly multiple sclerosis, through the application of immunotherapies and cell therapies. The company focuses on the development of EpiTCer-based therapies, which aim to modulate the immune response to autoreactive T-cells. Cellerys conducts clinical trials and collaborates with partners such as Novartis and TETEC to develop and market its therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Cellerys AG

✓ Offered
3
Immune Tolerance Therapy for Multiple Sclerosis
Immune tolerance therapies for autoimmune diseases, especially multiple sclerosis; development of therapies to restore immune tolerance without immunomodulation or immunosuppression.
CLS12311 therapy
CLS12311 as a treatment for multiple sclerosis; patients' own red blood cells are coupled ex vivo with peptides and, after reinfusion, used to induce antigen-specific tolerance.
RED4MS Clinical Study
Phase Ib/IIa clinical study to evaluate the safety, tolerability and efficacy of CLS12311 in relapsing-remitting multiple sclerosis.
Trust & reputation

ranQ Trust Score of Cellerys AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Cellerys AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Cellerys AG scores 84.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Cellerys AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Cellerys AG scores 28.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.28.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Cellerys AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Cellerys AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Cellerys AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cellerys AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cellerys AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 25
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-418.384.245
Founded
2015 · 11 years
Last commercial register change
July 22, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RI
    Repertoire Immune Medicines (Switzerland) AG
    Schlieren
    SB
    Swiss Bioscience GmbH
    Schlieren
    LB
    LimmaTech Biologics AG
    Schlieren
    CA
    CUTISS AG
    Schlieren
    MT
    Memo Therapeutics AG
    Schlieren
    EA
    Evax AG
    Zurich
    SA
    Stallergenes AG
    Dietlikon
    DT
    Denali Therapeutics CH GmbH
    Zurich